489 related articles for article (PubMed ID: 30854646)
1. Clinical and molecular characterization of early-onset colorectal cancer.
Willauer AN; Liu Y; Pereira AAL; Lam M; Morris JS; Raghav KPS; Morris VK; Menter D; Broaddus R; Meric-Bernstam F; Hayes-Jordan A; Huh W; Overman MJ; Kopetz S; Loree JM
Cancer; 2019 Jun; 125(12):2002-2010. PubMed ID: 30854646
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Implications of Mucinous Differentiation in Metastatic Colorectal Carcinoma Can Be Explained by Distinct Molecular and Clinicopathologic Characteristics.
Khan M; Loree JM; Advani SM; Ning J; Li W; Pereira AAL; Lam M; Raghav K; Morris VK; Broaddus R; Maru D; Overman MJ; Kopetz S
Clin Colorectal Cancer; 2018 Dec; 17(4):e699-e709. PubMed ID: 30205948
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic and molecular features of sporadic early-onset colorectal adenocarcinoma: an adenocarcinoma with frequent signet ring cell differentiation, rectal and sigmoid involvement, and adverse morphologic features.
Chang DT; Pai RK; Rybicki LA; Dimaio MA; Limaye M; Jayachandran P; Koong AC; Kunz PA; Fisher GA; Ford JM; Welton M; Shelton A; Ma L; Arber DA; Pai RK
Mod Pathol; 2012 Aug; 25(8):1128-39. PubMed ID: 22481281
[TBL] [Abstract][Full Text] [Related]
4. [Characterization of patients with sporadic colorectal cancer following the new Consensus Molecular Subtypes (CMS)].
Wielandt AM; Villarroel C; Hurtado C; Simian D; Zamorano D; Martínez M; Castro M; Vial MT; Kronberg U; López-Kostner F
Rev Med Chil; 2017 Apr; 145(4):419-430. PubMed ID: 28748988
[TBL] [Abstract][Full Text] [Related]
5. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
Kim JH; Bae JM; Cho NY; Kang GH
Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113
[TBL] [Abstract][Full Text] [Related]
6. CMS-dependent prognostic impact of KRAS and BRAFV600E mutations in primary colorectal cancer.
Smeby J; Sveen A; Merok MA; Danielsen SA; Eilertsen IA; Guren MG; Dienstmann R; Nesbakken A; Lothe RA
Ann Oncol; 2018 May; 29(5):1227-1234. PubMed ID: 29518181
[TBL] [Abstract][Full Text] [Related]
7. The increasing incidence of young-onset colorectal cancer: a call to action.
Ahnen DJ; Wade SW; Jones WF; Sifri R; Mendoza Silveiras J; Greenamyer J; Guiffre S; Axilbund J; Spiegel A; You YN
Mayo Clin Proc; 2014 Feb; 89(2):216-24. PubMed ID: 24393412
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancer.
Overman MJ; Adam L; Raghav K; Wang J; Kee B; Fogelman D; Eng C; Vilar E; Shroff R; Dasari A; Wolff R; Morris J; Karunasena E; Pisanic TR; Azad N; Kopetz S
Ann Oncol; 2018 Jan; 29(1):139-144. PubMed ID: 29069279
[TBL] [Abstract][Full Text] [Related]
9. Dietary Patterns and Risk of Colorectal Cancer: Analysis by Tumor Location and Molecular Subtypes.
Mehta RS; Song M; Nishihara R; Drew DA; Wu K; Qian ZR; Fung TT; Hamada T; Masugi Y; da Silva A; Shi Y; Li W; Gu M; Willett WC; Fuchs CS; Giovannucci EL; Ogino S; Chan AT
Gastroenterology; 2017 Jun; 152(8):1944-1953.e1. PubMed ID: 28249812
[TBL] [Abstract][Full Text] [Related]
10. Clinical and molecular features of young-onset colorectal cancer.
Ballester V; Rashtak S; Boardman L
World J Gastroenterol; 2016 Feb; 22(5):1736-44. PubMed ID: 26855533
[TBL] [Abstract][Full Text] [Related]
11. Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry.
Yurgelun MB; Masciari S; Joshi VA; Mercado RC; Lindor NM; Gallinger S; Hopper JL; Jenkins MA; Buchanan DD; Newcomb PA; Potter JD; Haile RW; Kucherlapati R; Syngal S;
JAMA Oncol; 2015 May; 1(2):214-21. PubMed ID: 26086041
[TBL] [Abstract][Full Text] [Related]
12. Epigenetics could explain some Moroccan population colorectal cancers peculiarities: microsatellite instability pathway exploration.
Sekal M; Ameurtesse H; Chbani L; Ouldim K; Bennis S; Abkari M; Boulouz A; Benajah DA; Benjelloun B; Ousadden A; Ait Taleb K; Ait Laalim S; Toghrai I; Mazaz K; Arifi S; Mellas N; El Rhazi K; Harmouch T; Ibrahimi SA; Amarti Riffi A
Diagn Pathol; 2015 Jun; 10():77. PubMed ID: 26104511
[TBL] [Abstract][Full Text] [Related]
13. Association of Consensus Molecular Subtypes and Molecular Markers With Clinical Outcomes in Patients With Metastatic Colorectal Cancer: Biomarker Analyses From LUME-Colon 1.
Lenz HJ; Argiles G; Yoshino T; Tejpar S; Ciardiello F; Braunger J; Salnikov AV; Gabrielyan O; Schmid R; Höfler J; Kitzing T; Van Cutsem E
Clin Colorectal Cancer; 2021 Mar; 20(1):84-95.e8. PubMed ID: 33041226
[TBL] [Abstract][Full Text] [Related]
14. Advanced-Stage Colorectal Cancer in Persons Younger Than 50 Years Not Associated With Longer Duration of Symptoms or Time to Diagnosis.
Chen FW; Sundaram V; Chew TA; Ladabaum U
Clin Gastroenterol Hepatol; 2017 May; 15(5):728-737.e3. PubMed ID: 27856366
[TBL] [Abstract][Full Text] [Related]
15. Characterization of Chilean patients with sporadic colorectal cancer according to the three main carcinogenic pathways: Microsatellite instability, CpG island methylator phenotype and Chromosomal instability.
Wielandt AM; Hurtado C; Moreno C M; Villarroel C; Castro M; Estay M; Simian D; Martinez M; Vial MT; Kronberg U; López-Köstner F
Tumour Biol; 2020 Jul; 42(7):1010428320938492. PubMed ID: 32635826
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological Characteristics and Outcome of Adolescent and Young Adult-Onset Microsatellite Stable Colorectal Cancer Patients.
Sukhokanjanachusak K; Pongpaibul A; Nimmannit A; Akewanlop C; Korphaisarn K
J Adolesc Young Adult Oncol; 2021 Oct; 10(5):573-580. PubMed ID: 33085547
[No Abstract] [Full Text] [Related]
17. Age at onset should be a major criterion for subclassification of colorectal cancer.
Perea J; Rueda D; Canal A; Rodríguez Y; Álvaro E; Osorio I; Alegre C; Rivera B; Martínez J; Benítez J; Urioste M
J Mol Diagn; 2014 Jan; 16(1):116-26. PubMed ID: 24184227
[TBL] [Abstract][Full Text] [Related]
18. Associations of non-pedunculated T1 colorectal adenocarcinoma outcome with consensus molecular subtypes, immunoscore, and microsatellite status: a multicenter case-cohort study.
Haasnoot KJC; Backes Y; Moons LMG; Kranenburg O; Trinh A; Vermeulen L; Noë M; Tuynman JB; van Lent AUG; van Ginneken R; Seldenrijk CA; Raicu MG; Trumpi K; Ubink I; Milne AN; Boonstra JJ; Groen JN; Schwartz MP; Wolfhagen FHJ; Geesing JMJ; Ter Borg F; Brosens LAA; van Bergeijk J; Spanier BWM; de Vos Tot Nederveen Cappel WH; Kessels K; Seerden TCJ; Vleggaar FP; Offerhaus GJA; Siersema PD; Elias SG; Laclé MM;
Mod Pathol; 2020 Dec; 33(12):2626-2636. PubMed ID: 32581367
[TBL] [Abstract][Full Text] [Related]
19. Contributions of Adenocarcinoma and Carcinoid Tumors to Early-Onset Colorectal Cancer Incidence Rates in the United States.
Montminy EM; Zhou M; Maniscalco L; Abualkhair W; Kim MK; Siegel RL; Wu XC; Itzkowitz SH; Karlitz JJ
Ann Intern Med; 2021 Feb; 174(2):157-166. PubMed ID: 33315473
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation.
Lee S; Cho NY; Choi M; Yoo EJ; Kim JH; Kang GH
Pathol Int; 2008 Feb; 58(2):104-13. PubMed ID: 18199160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
